complications flexible ureteroscopy percutaneous nephrolithotomy (PCNL) renal calculi stone-free rate a b s t r a c t As the renal stone size increases, the stone clearance rate using extracorporeal shock wave lithotripsy (ESWL) for renal calculi decreases. For stone sizes >2 cm in diameter, the stone clearance rate of ESWL is unsatisfactory. Thereafter, percutaneous nephrolithotomy (PCNL) is the preferred treatment of choice because of a better stone-free rate. However, increased complications and a longer convalescence period with PCNL became more important issues in certain cases. Previous literature reviews reported that ureteroscopic lithotripsy (URSL) can be used as adjunct therapy in combination with PCNL. Some authors even reported an excellent stone-free rate with minimal complications by performing URSL for large renal calculi. Because of the availability of technologically advanced ureteroscope and improved ancillary equipment, such as the holmium laser and ureteral access sheath, this procedure has become more feasible and effective for treating renal calculi. In addition to reviewing stone-free and complication rates, the literature was also reviewed for the total number of procedures carried out, and medical expenses were compared although only a few reports are available on this subject. The contemporary literature supports URSL as a safer, more-efficient, and more cost-effective alternative to PCNL in selected patients.
Introduction
In the era of extracorporeal shock wave lithotripsy (ESWL), the stone clearance rate for renal calculi was found to decrease as the stone sizes increase, especially with stone sizes >2 cm in diameter. 1 Therefore, ESWL is recommended only when the size of a renal calculus is <2 cm in diameter. Percutaneous nephrolithotomy (PCNL) is favored when the size of a renal calculus is >2 cm. According to the American Urological Association (AUA) treatment guidelines in 2005 and an announcement of the Taiwan Urological Association on its website, PCNL is the first choice of treatment for the majority of staghorn stones that are >500 mm 2 or >2.5 cm in standardized index patients. 2, 3 The earlier literature reported that ureteroscopic lithotripsy (URSL) was considered an adjunct therapy in combination with PCNL for staghorn stones. 4 Considering major complications arising out of performing a PCNL, in addition to technological advancements of flexible ureteroscopes and ancillary equipment, such as the holmium laser and ureteral access sheath, flexible ureteroscopy with holmium laser lithotripsy was proven to be a feasible and an effective alternative therapy with low morbidities in selected patients, whose renal stones are not <2 cm. 5e7 From these considerations, here we present a review of the literature with regard to stone-free rates, complications, the number of procedures needed, and cost analysis.
Stone-free rate and the number of procedures needed
The mean stone clearance rate for PCNL is 78% (73e84%), with an average of 1.9 procedures per patient. The mean stone clearance rate for PCNL with a partial staghorn stone is 74% (51e91%), while the mean stone clearance rate for PCNL with a complete staghorn stone is 65% (49e79%) 2, 8, 9 which is obviously lower. Because of the improvements in endoscopic equipment and technological advancements in recent years, the application of PCNL for treating renal calculi in pediatric patients was reported. Boorman et al. and Samad et al. reported that using PCNL for treating children with renal calculi, the original stone clearance rates were around 58% and 59%, respectively; and cumulative stone clearance rates increased to approximately 81e94% after adjuvant therapy. From the literature mentioned above, the stone clearance rate of monotherapy with PCNL in pediatric patients is limited and adjuvant therapies are often needed. 10, 11 The earlier literature demonstrated that flexible ureteroscopy in combination with auxiliary equipment, such as a ureteral access sheath, could be used as adjunctive therapy to facilitate stone clearance during the procedure and improve the stone clearance rate, 4 while some literature demonstrated that the mean stone clearance rate for flexible ureteroscopy with holmium laser lithotripsy was 89.3% (approximately 85.1e93.3%) with an average of 1.5 procedures per patient (approximately 1.3e2.3 procedures per patient) (Table 1 ). 6,12e15
Complications
Lee et al. 16 and Reddy et al. 17 in early reports also pointed out that PCNL had a higher complication rate and a longer convalescence period compared with ureteroscopy. Lee et al. reported that the complication rate with PCNL was 4% in 582 patients. Major complications included death (2/582 cases, 0.3%), bleeding that necessitated intervention, urinary tract injuries (urinoma formation, renal pelvic lacerations, ureteral avulsion, and ureteropelvic or ureteral stricture), and injuries to adjacent organs (pneumothorax, hemothorax, and bowel injury). 16 The AUA guidelines in 2005 reported that the complication rate for PCNL was about 15% (approximately 7e27%) with acute complication rates of around 5% and mortality rates of around 2% (four deaths in 210 cases). 2 Boorman et al. and Samad et al. reported that major complication rates of PCNL when treating children with renal calculi were 9% (one blood transfusion and one urosepsis among 23 patients) and 4% (seven blood transfusions among 169 patients). 10, 11 From a review of the literature in Table 1 , the complication rate for ureteroscopic management of renal calculi >2 cm was 11.6% (5.8e18.2%) (18 of 155 cases). There was only 1 case of the 155 cases analyzed, <1%, that experienced a cerebral vascular accident postoperatively. 6,12e15 No deaths were reported.
As a result of instrument improvements, miniaturization of ureteroscopes and ancillary devices, and the introduction of the holmium laser, indications for ureteroscopy are evolving. Tan et al. reported a 95% stone-free rate without surgical complications in ureteroscopic management of pediatric renal calculi. 18 Watterson et al. reported an 89% overall stone-free rate without obstetric or urologic complications for symptomatic calculi in pregnant patients for whom conservative therapy had failed. 19 In morbidly obese patients who suffer from urolithiasis, there are limited treatment options. ESWL and PCNL may be difficult in these patients, and ureteroscopy is an alternative procedure of choice with minimal invasiveness. Dash et al. reported that ureteroscopic treatment of renal calculi is a safe and effective first-line treatment for renal calculi in morbidly obese patients with an overall success rate of 83%. 20 Wheat et al. reported that planned multisession retrograde endoscopic lithotripsy (REL) is a safe alternative to PCNL in morbidly obese patients, who suffer from renal stones >2.0 cm in diameter, which cause difficulties with implementing PCNL. 21 Although the stone-free rate after final treatment is expected to be low, it was actually 33%, because of the complexity of cases, while there were no intraoperative complications with multisession REL. Riley et al. reported similar planned multisession ureteroscopy with holmium laser lithotripsy for patients with stone diameters >2.5 cm as an alternative treatment option to PCNL. The overall stone-free rate was 90.9%. The complication rate was 18.2%, and no major complications were reported. 15 Turna et al. reported a retrospectively matched cohort study which indicated that flexible ureteroscopy with holmium laser lithotripsy is safe and effective for renal calculi in patients on anticoagulant therapy. It does not require perioperative manipulation, because it neither increases the risk of bleeding nor reduces the stone-free rate in the anticoagulant group. 22 
Cost analysis
Because the national health insurance policy in Taiwan uses a global budget to control total health-care expenses, the cost of disease treatment also needs to be taken into consideration. A retrospective study reported that the cost for PCNL was significantly higher than that of flexible ureteroscopy with holmium laser lithotripsy. 23 Because only limited reports are available regarding the cost of treatment in this field, the author tried to analyze the estimated costs of similar cases in our hospital. The cost of PCNL was estimated to be NT$57,102 (NT$ ¼ New Taiwan dollar; in 2011, the estimated average exchange rate was US$1.00 z NT$30.00) with a hospital stay of 8 days, while the cost of flexible URSL with holmium laser lithotripsy was estimated to be NT$36,708 with a hospital stay of 4 days. This result is similar to the report above, which found that the cost of PCNL was significantly higher than that of flexible ureteroscopy with holmium laser lithotripsy. The hospital stay was also significantly shorter for flexible ureteroscopy, and this might be attributed to its less invasiveness and minimal complications.
Conclusions
With evolving techniques and advancements in instrumentation, indications for ureteroscopic treatment of renal calculi are increasing because of excellent stone-free rates and minimal major complications. 24, 25 In considering the overall risks and major complications of PCNL, ureteroscopy with holmium laser lithotripsy and REL is a safe and efficient alternative to PCNL in selective patients, even in those with renal stones >2.0 cm in diameter.
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